BSE filing, NSE: IGLSPIRITS. Summary written from the filing by ALFA Finder's alert engine.
IGL Spirits Ltd: key numbers
- Share price
- ₹796.07
- Market cap
- ₹5,336 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.00 Cr
- Promoter holding
- 59.63%
- FII holding
- 2.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IGL Spirits Ltd
All →IGL Spirits Earnings Call Transcript: Key Takeaways
Gross revenue +10% but net revenue down ~8%; EBITDA flat at ₹125 Cr, margin up 120bps on IMFL mix. PAT rise mainly from lower interest costs.
IGL Spirits Investor Presentation: Key Takeaways
Q2 FY27 net revenue ₹706 Cr (-7.2%), EBITDA flat at ₹125 Cr, margin 17.7% (+129 bps), PAT ₹61 Cr (+6.3%). IMFL mix rising. FY27 EBITDA guidance ₹500–550 Cr.
IGL Spirits Results Update
IGL Spirits reported Q2 FY27 revenue of ₹2,295 Cr (up 10.3% YoY) and PAT of ₹61.20 Cr. These are its first comparative results post-demerger from India Glycols.
IGL Spirits Q2 FY27 Results: Net Profit ₹61.2 Cr, Up 6.3% YoY
IGL Spirits reported unaudited results for the quarter and half year ended September 2026. Revenue and profit figures are included in the attached statement.
- Key figure
- Net profit ₹61.2 Cr · +6.3% YoY
IGL Spirits Other Announcement
IGL Spirits' board approved adopting a new Articles of Association to align with Securities Contracts Rules and group governance. Shareholder and regulatory approvals are still required.
IGL Spirits Management Change
IGL Spirits designated five senior management personnel, effective 12 November 2026. The appointments follow the Nomination and Remuneration Committee's recommendation.
Other credit rating announcements
All →High Energy Batteries (India) Credit Rating
India Ratings reaffirmed High Energy Batteries' bank loan facilities at IND BBB/Stable/IND A3+. The rating covers INR 75 crore of facilities and the outlook remains stable.
Ennature Bio Pharma Credit Rating
CARE Ratings assigned Ennature Bio Pharma CARE A-; Stable long-term and CARE A2+ short-term ratings. The ratings cover bank facilities totalling Rs.100 Crore.
Canara Bank Credit Rating
Moody's affirmed Canara Bank's Baa3 ratings and upgraded its baseline credit assessment to baa3 from ba1, with a stable outlook. Asset quality and capital improved.
Arman Financial Services Credit Rating
Arman Financial Services disclosed that CARE Ratings reaffirmed its 'CARE A-; Stable' rating on NCD facilities aggregating Rs 90.89 crore. The letter is dated November 19, 2026.
Genus Power Infrastructures Credit Rating
CRISIL reaffirmed Genus Power's bank facilities rating at AA-/Positive and A1+ on commercial paper. The long-term outlook was revised from Stable to Positive.
Pace Digitek Credit Rating
CRISIL revised Pace Digitek's long-term outlook to Positive and assigned A-/Positive to proposed Rs.400 Crore NCDs. Bank facilities of Rs.1400 Crore were reaffirmed at A-/Positive and A2+.